New location technology will help get emergency responders closer to 911 callers if they are unable to describe their location. Photo courtesy of AT&T

“911, what’s your location?”

It’s a phrase we’ve heard hundreds of times on TV shows and movies. In real life though, have you ever considered the possibility that this question — one that can mean the difference between life and death — may be hard for the caller to answer? In an emergency, you may not be able to speak. If you’re in a car accident, you may not know where you are. In a disaster, your surroundings may be confusing.

That’s where a new location-based routing feature we call “Locate Before Route” comes in. This summer, AT&T, in collaboration with Intrado, rolled out a first-of-its-kind 911 upgrade across the country that will make it easier for emergency personnel to find and send help to wireless callers.

Roughly 80 percent of 911 calls today are made from cell phones. Before location-based routing, a call would ping a cell phone tower and connect to the dispatch center closest to that tower. But here’s the thing: that cell tower could be up to 10 miles away. Imagine needing help in Deer Park but the dispatcher thinking you may be in Baytown. You could even be in a different county, making it difficult for dispatchers to pinpoint exactly where the call is calling from.

Here’s how it works:

Instead of pinging the closest cell tower, the GPS in your phone connects with the closest 911 dispatch center, meaning emergency operators can locate you within about 55 yards of your position. That’s about half a football field.

This kind of accuracy means public safety can respond faster, especially in situations when a 911 wireless caller doesn’t know or can’t disclose their location.

AT&T is the first wireless carrier to launch location-based routing for all 911 call centers nationwide, whether they’re operating on older technology or NextGen 911. The best part: AT&T customers across the country automatically have access to this service – no action is necessary.

AT&T’s commitment to public safety is longstanding. Following the events of September 11th, we worked to create FirstNet, – the only nationwide communications platform dedicated to public safety and first responders. With nationwide location-based 911 call routing, we are providing our customers with the quickest, most accurate way to call emergency personnel for help when it’s most needed.

------

Luis Silva is vice president and general manager at AT&T.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.